Travere Therapeutics Inc - Company Profile
Powered by
All the data and insights you need on Travere Therapeutics Inc in one report.
- Save hours of research time and resources with
our up-to-date Travere Therapeutics Inc Strategy Report
- Understand Travere Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Travere Therapeutics Inc (Travere Therapeutics), formerly Retrophin Inc, is an integrated biopharmaceutical company that develops and markets therapies for the treatment of people with rare diseases with unmet medical needs. Increasing product revenues, strong market potential, and R&D focus are its strengths even as a history of operating losses could be a major cause for concern for the company. Travere Therapeutics could benefit from orphan drug and fast track designations; the unmet clinical need of pantothenate kinase-associated neurodegeneration and regulatory approvals. However, stiff competition and stringent regulations could affect the company's growth prospects.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer